Edwards Lifesciences Corp (EW)
85.25
+0.19
(+0.22%)
USD |
NYSE |
May 03, 16:00
85.27
+0.02
(+0.02%)
After-Hours: 20:00
Edwards Lifesciences Revenue (Annual): 6.005B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.005B |
| December 31, 2022 | 5.382B |
| December 31, 2021 | 5.232B |
| December 31, 2020 | 4.386B |
| December 31, 2019 | 4.348B |
| December 31, 2018 | 3.723B |
| December 31, 2017 | 3.435B |
| December 31, 2016 | 2.964B |
| December 31, 2015 | 2.494B |
| December 31, 2014 | 2.323B |
| December 31, 2013 | 2.046B |
| December 31, 2012 | 1.900B |
| December 31, 2011 | 1.679B |
| Date | Value |
|---|---|
| December 31, 2010 | 1.447B |
| December 31, 2009 | 1.321B |
| December 31, 2008 | 1.238B |
| December 31, 2007 | 1.091B |
| December 31, 2006 | 1.037B |
| December 31, 2005 | 997.90M |
| December 31, 2004 | 931.50M |
| December 31, 2003 | 860.50M |
| December 31, 2002 | 704.00M |
| December 31, 2001 | 692.10M |
| December 31, 2000 | 804.00M |
| December 31, 1999 | 905.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
4.348B
Minimum
2019
6.005B
Maximum
2023
5.071B
Average
5.232B
Median
2021
Revenue (Annual) Benchmarks
| Stryker Corp | 20.50B |
| Align Technology Inc | 3.862B |
| Abbott Laboratories | 40.11B |
| Boston Scientific Corp | 14.24B |
| Steris PLC | 4.958B |